Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Seems implied that the Phase 1 trials should be run and the ball rolling well when they go NASDAQ. $100M+ MC? A well-handled set of PRs showing the progress is needed over the next couple months.

Stroke recovery and Cancer tumor treatments are excellent choices for AGN, IMO.

CC can wait until data from the Ausi IPF/CC Phase 2 CT is presented, when these paths are proven or not. IMO.

Math of $2+M in the books implies patience for long time shareholders and restraint from unneeded dilution by the company, IMO. The current pps is well below most folks' average and attractive compared to others.

The converted management shares are now the same as ours and capitol raises are not needed yet, IMO. Tax loss sellers also may return soon. JMHOs. All Good...GLTA...